Virtual meeting routine
TBMED 4th Progress Meeting to kick-off the second half of the project
TBMED started the new year and the second half of the project’s duration with its 4th Progress Meeting held virtually on January 27-28, 2021. Despite working under the persistent constraints of the Covid-19 pandemic, which imposed some delays in the first half of 2020, the partners were able to adapt their workplan and make good progress towards their objectives.
The TBMED scientific partners continue to work closely together in the three TBMED case studies focusing on Glycobone, Keratoprosthesis and hyperthermia treatment. While there are some minor issues reported during the meeting that need to be resolved in the next few months, the work in the case studies, and particularly the experience with overcoming problems, offers TBMED the unique opportunity to learn from them and implement those lessons learned in setting up the services for the future OITB.
Besides the scientific progress, building the OITB was the second focus of the TBMED meeting as it is foreseen to be launched by the end of the year. However, since the OITB will not be the only outcome of TBMED, the consortium held an exploitation workshop to identify the partners’ Key Exploitable Results stemming from their individual work in the project. 2021 will be a very work-intensive but also exciting year for the project to which all the partners are looking forward.